{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:18:09Z","timestamp":1786979889702,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00259-023-06573-x","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T23:34:16Z","timestamp":1703288056000},"page":"1345-1348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Expanding the clinical indications of [18F]fluorocholine PET\/CT in primary hyperparathyroidism: the evidence cannot be evaded"],"prefix":"10.1007","volume":"51","author":[{"given":"Giorgio","family":"Treglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,23]]},"reference":[{"issue":"11","key":"6573_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jacr.2021.08.013","volume":"18","author":"D Zander","year":"2021","unstructured":"Expert Panel on Neurological Imaging, Zander D, Bunch PM, Policeni B, Juliano AF, Carneiro-Pla D, Dubey P, Gule-Monroe MK, Hagiwara M, Hoang JK, Jain V, Kim LT, Moonis G, Parsons MS, Rath TJ, Sol\u00f3rzano CC, Subramaniam RM, Taheri MR, DuCheneThoma K, Trout AT, Zafereo ME Jr, Corey AS. ACR appropriateness criteria\u00ae parathyroid adenoma. J Am Coll Radiol. 2021;18(11):406\u201322. https:\/\/doi.org\/10.1016\/j.jacr.2021.08.013.","journal-title":"J Am Coll Radiol."},{"issue":"2","key":"6573_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.23736\/S0391-1977.17.02685-2","volume":"43","author":"G Treglia","year":"2018","unstructured":"Treglia G, Trimboli P, Huellner M, Giovanella L. Imaging in primary hyperparathyroidism: focus on the evidence-based diagnostic performance of different methods. Minerva Endocrinol. 2018;43(2):133\u201343. https:\/\/doi.org\/10.23736\/S0391-1977.17.02685-2.","journal-title":"Minerva Endocrinol"},{"issue":"35","key":"6573_CR3","doi-asserted-by":"publisher","first-page":"e34622","DOI":"10.1097\/MD.0000000000034622","volume":"102","author":"H G\u00f6b\u00fct","year":"2023","unstructured":"G\u00f6b\u00fct H, Bostanci H. The evolution of primary hyperparathyroidism publications and global productivity from past to present: a bibliometric analysis during 1980 to 2022. Medicine. 2023;102(35):e34622. https:\/\/doi.org\/10.1097\/MD.0000000000034622.","journal-title":"Medicine"},{"issue":"2","key":"6573_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.23736\/S1824-4785.23.03512-4","volume":"67","author":"E Quak","year":"2023","unstructured":"Quak E, Cavarec M, Ciappuccini R, Girault G, Rouzier R, Lequesne J. Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism. Q J Nucl Med Mol Imaging. 2023;67(2):122\u20139. https:\/\/doi.org\/10.23736\/S1824-4785.23.03512-4.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"6573_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/cen.14875","volume":"99","author":"DD Patel","year":"2023","unstructured":"Patel DD, Bhattacharjee S, Pandey AK, Kopp CR, Ashwathanarayana AG, Patel HV, Barnabas R, Bhadada SK, Dodamani MH. Comparison of 4D computed tomography and F-18 fluorocholine PET for localisation of parathyroid lesions in primary hyperparathyroidism: a systematic review and meta-analysis. Clin Endocrinol. 2023;99(3):262\u201371. https:\/\/doi.org\/10.1111\/cen.14875.","journal-title":"Clin Endocrinol"},{"issue":"2","key":"6573_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12020-021-02798-8","volume":"74","author":"A Piccardo","year":"2021","unstructured":"Piccardo A, Bottoni G, Boccalatte LA, Camponovo C, Musumeci M, Bacigalupo L, Collaud C, Ugolini M, Fiz F, Trimboli P. Head-to-head comparison among 18F-choline PET\/CT, 4D contrast-enhanced CT, and 18F-choline PET\/4D contrast-enhanced CT in the detection of hyperfunctioning parathyroid glands: a systematic review and meta-analysis. Endocrine. 2021;74(2):404\u201312. https:\/\/doi.org\/10.1007\/s12020-021-02798-8.","journal-title":"Endocrine"},{"issue":"8","key":"6573_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaoto.2021.0915","volume":"147","author":"SW Lee","year":"2021","unstructured":"Lee SW, Shim SR, Jeong SY, Kim SJ. Direct comparison of preoperative imaging modalities for localization of primary hyperparathyroidism: a systematic review and network meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147(8):692\u2013706. https:\/\/doi.org\/10.1001\/jamaoto.2021.0915.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"6573_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1530\/EJE-21-0038","volume":"185","author":"F Bioletto","year":"2021","unstructured":"Bioletto F, Barale M, Parasiliti-Caprino M, Prencipe N, Berton AM, Procopio M, Deandreis D, Ghigo E. Comparison of the diagnostic accuracy of 18F-fluorocholine PET and 11C-methionine PET for parathyroid localization in primary hyperparathyroidism: a systematic review and meta-analysis. Eur J Endocrinol. 2021;185(1):109\u201320. https:\/\/doi.org\/10.1530\/EJE-21-0038.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"6573_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.2967\/jnumed.120.257303","volume":"62","author":"J Whitman","year":"2021","unstructured":"Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA. Assessment and comparison of 18F-fluorocholine PET and <sup>99m<\/sup>Tc-sestamibi scans in identifying parathyroid adenomas: a metaanalysis. J Nucl Med. 2021;62(9):1285\u201391. https:\/\/doi.org\/10.2967\/jnumed.120.257303.","journal-title":"J Nucl Med"},{"issue":"9","key":"6573_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s12149-020-01507-1","volume":"34","author":"L Evangelista","year":"2020","unstructured":"Evangelista L, Ravelli I, Magnani F, Iacobone M, Giraudo C, Camozzi V, Spimpolo A, Cecchin D. 18F-choline PET\/CT and PET\/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature. Ann Nucl Med. 2020;34(9):601\u201319. https:\/\/doi.org\/10.1007\/s12149-020-01507-1.","journal-title":"Ann Nucl Med"},{"issue":"8","key":"6573_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/jamaoto.2019.0574","volume":"145","author":"LA Boccalatte","year":"2019","unstructured":"Boccalatte LA, Higuera F, G\u00f3mez NL, de la Torre AY, Mazzaro EL, Galich AM, Collaud C, Figari MF. Usefulness of 18F-fluorocholine positron emission tomography-computed tomography in locating lesions in hyperparathyroidism: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(8):743\u201350. https:\/\/doi.org\/10.1001\/jamaoto.2019.0574.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"6573_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MNM.0000000000000952","volume":"40","author":"WAM Broos","year":"2019","unstructured":"Broos WAM, van der Zant FM, Knol RJJ, Wondergem M. Choline PET\/CT in parathyroid imaging: a systematic review. Nucl Med Commun. 2019;40(2):96\u2013105. https:\/\/doi.org\/10.1097\/MNM.0000000000000952.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"6573_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","volume":"46","author":"G Treglia","year":"2019","unstructured":"Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, Giovanella L. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46(3):751\u201365. https:\/\/doi.org\/10.1007\/s00259-018-4123-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"6573_CR14","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12672-018-0347-4","volume":"9","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Lee SW, Jeong SY, Pak K, Kim K. Diagnostic performance of F-18 fluorocholine PET\/CT for parathyroid localization in hyperparathyroidism: a systematic review and meta-analysis. Horm Cancer. 2018;9(6):440\u20137. https:\/\/doi.org\/10.1007\/s12672-018-0347-4.","journal-title":"Horm Cancer"},{"key":"6573_CR15","doi-asserted-by":"publisher","first-page":"1148287","DOI":"10.3389\/fmed.2023.1148287","volume":"10","author":"A Imperiale","year":"2023","unstructured":"Imperiale A, Bani J, Bottoni G, Latg\u00e9 A, Heimburger C, Catrambone U, Vix M, Treglia G, Piccardo A. Does 18F-fluorocholine PET\/CT add value to positive parathyroid scintigraphy in the presurgical assessment of primary hyperparathyroidism? Front Med. 2023;10:1148287. https:\/\/doi.org\/10.3389\/fmed.2023.1148287.","journal-title":"Front Med"},{"issue":"12","key":"6573_CR16","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.3390\/diagnostics11122384","volume":"11","author":"A Latge","year":"2021","unstructured":"Latge A, Riehm S, Vix M, Bani J, Ignat M, Pretet V, Helali M, Treglia G, Imperiale A. 18F-Fluorocholine PET and 4D-CT in patients with persistent and recurrent primary hyperparathyroidism. Diagnostics. 2021;11(12):2384. https:\/\/doi.org\/10.3390\/diagnostics11122384.","journal-title":"Diagnostics"},{"issue":"2","key":"6573_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.23736\/S1824-4785.23.03514-8","volume":"67","author":"F Fiz","year":"2023","unstructured":"Fiz F, Bottoni G, Massollo M, Trimboli P, Catrambone U, Bacigalupo L, Righi S, Treglia G, Imperiale A, Piccardo A. [18F]F-Choline PET\/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies? Q J Nucl Med Mol Imaging. 2023;67(2):130\u20137. https:\/\/doi.org\/10.23736\/S1824-4785.23.03514-8.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"6573_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00259-018-4147-4","volume":"46","author":"A Piccardo","year":"2019","unstructured":"Piccardo A, Trimboli P, Rutigliani M, Puntoni M, Foppiani L, Bacigalupo L, Crescenzi A, Bottoni G, Treglia G, Paparo F, Del Monte P, Lanata M, Paone G, Ferrarazzo G, Catrambone U, Arlandini A, Ceriani L, Cabria M, Giovanella L. Additional value of integrated 18F-choline PET\/4D contrast-enhanced CT in the localization of hyperfunctioning parathyroid glands and correlation with molecular profile. Eur J Nucl Med Mol Imaging. 2019;46(3):766\u201375. https:\/\/doi.org\/10.1007\/s00259-018-4147-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"6573_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-020-02487-y","volume":"71","author":"L Giovanella","year":"2021","unstructured":"Giovanella L, Bacigalupo L, Treglia G, Piccardo A. Will 18F-fluorocholine PET\/CT replace other methods of preoperative parathyroid imaging? Endocrine. 2021;71(2):285\u201397. https:\/\/doi.org\/10.1007\/s12020-020-02487-y.","journal-title":"Endocrine"},{"issue":"9","key":"6573_CR20","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","volume":"48","author":"P Petranovi\u0107 Ov\u010dari\u010dek","year":"2021","unstructured":"Petranovi\u0107 Ov\u010dari\u010dek P, Giovanella L, Carri\u00f3 Gasset I, Hindi\u00e9 E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48(9):2801\u201322. https:\/\/doi.org\/10.1007\/s00259-021-05334-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"6573_CR21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","volume":"37","author":"JP Bilezikian","year":"2022","unstructured":"Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML, International Workshop on Primary Hyperparathyroidism. Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res. 2022;37(11):2293\u2013314. https:\/\/doi.org\/10.1002\/jbmr.4677.","journal-title":"J Bone Miner Res."},{"key":"6573_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06537-1","author":"A Boucher","year":"2023","unstructured":"Boucher A, Delabie J, Lussey-Lepoutre C, Haissaguerre M, Ouvrard E, Lavinia V, Le Bras M, Batisse-Lignier M, Cuny T, Jacquet-Francillon N, Gaujoux S, Molina O, Imperiale A, Latge A, Ansquer C, Kelly A, Borson-Chazot F, Tlili G, Sebag F, Hamidou Z, Romanet P, Ta\u00efeb D. Performance of [18F]fluorocholine PET\/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent\/recurrent disease. Eur J Nucl Med Mol Imaging. 2023. https:\/\/doi.org\/10.1007\/s00259-023-06537-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"6573_CR23","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/cpf.12391","volume":"38","author":"M July","year":"2018","unstructured":"July M, Santhanam P, Giovanella L, Treglia G. Role of positron emission tomography imaging in multiple endocrine neoplasia syndromes. Clin Physiol Funct Imaging. 2018;38(1):4\u20139. https:\/\/doi.org\/10.1111\/cpf.12391.","journal-title":"Clin Physiol Funct Imaging"},{"issue":"7","key":"6573_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1159\/000511791","volume":"111","author":"B Niederle","year":"2021","unstructured":"Niederle B, Selberherr A, Bartsch DK, Brandi ML, Doherty GM, Falconi M, Goudet P, Halfdanarson TR, Ito T, Jensen RT, Larghi A, Lee L, \u00d6berg K, Pavel M, Perren A, Sadowski SM, Tonelli F, Triponez F, Valk GD, O\u2019Toole D, Scott-Coombes D, Thakker RV, Thompson GB, Treglia G, Wiedenmann B. Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome - an international consensus statement. Neuroendocrinology. 2021;111(7):609\u201330. https:\/\/doi.org\/10.1159\/000511791.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"6573_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s12020-022-03280-9","volume":"80","author":"A Rizzo","year":"2023","unstructured":"Rizzo A, Racca M, Cauda S, Balma M, Dall'Armellina S, Dionisi B, Mossetti C, Bruna MC, Freddi M, Palestini N. 18F-fluorocholine PET\/CT semi-quantitative analysis in patients affected by primary hyperparathyroidism: a comparison between laboratory and functional data. Endocrine. 2023;80(2):433\u201340. https:\/\/doi.org\/10.1007\/s12020-022-03280-9.","journal-title":"Endocrine"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06573-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06573-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06573-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:06:06Z","timestamp":1711004766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06573-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,23]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6573"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06573-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,23]]},"assertion":[{"value":"23 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable to this editorial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical\u00a0approval"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}